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Notch-4 activationThe colony of wild mice, named Jyg, has been shown to express an exogenous mouse mammary tumor virus
(Jyg-MMTV). This virus induces mammary tumors in its natural host at a high incidence (≈80%) resulting
from insertion mutations in Notch-4 (43%), Wnt-1 (26%), and Fgf-3 (13%). Since the activation of Notch-4 is
not common in mammary tumors of standard laboratory strains of mice infected with various MMTV strains,
we examined the consequences of Jyg-MMTV infection in BALB/c and C57BL/6 mice. The results show that
Jyg-MMTV induces mammary tumors in both mouse strains, but the incidence of mammary tumors in BALB/
c mice is greater than in C57BL/6 mice. Surprisingly, however, none of the 75 mammary tumors, analyzed
both by Southern and Northern hybridizations, showed insertion mutations in or expression of Notch-4. In
contrast, both Wnt-1 and Fgf-3 were found to be involved in these tumors. Our ﬁndings may suggest, among
other possibilities, the existence of a structural difference(s) between laboratory and wild mice at the Notch-
4 locus that regulates the integration of Jyg-MMTV proviral DNA.© 2009 Elsevier Inc. All rights reserved.IntroductionMouse mammary tumor virus (MMTV), a type B retrovirus, has
been shown to be the etiologic agent of mammary adenocarcinomas
in several inbred strains of mice. Although all laboratory mouse
strains, including some feral mice, carry in their genome stably
integrated MMTV proviruses (endogenous Mtvs), the virus that
causes mammary tumors at a high incidence (N80%) is usually
transmitted exogenously frommother to daughter via milk (Moore et
al., 1979). Only a few endogenous proviruses such as Mtv-1 in C3H
mice andMtv-2 in GRmice, are expressed in mammary glands leading
to the production of infectious virus particles that induce mammary
tumors in the host animals, and, in addition, infect pups receivingmilk
from their mothers (Kozak et al., 1987). However, they differ in their
biological outcome: while the GR-Mtv-2 virus induces mammary
tumors at an early age (b6–8 months) with a high incidence (N90%),
tumors developed by the C3H-Mtv-1 virus have a moderate incidence
(b50%) and a long latency period (N20 months).
Previously, a number of studies have examined the distribution of
exogenous/endogenous MMTVs in several populations of wild mice
from different geographical regions in the USA, Europe and China
(Callahan et al., 1982; Cohen and Varmus, 1979; Gallahan and
Callahan, 1987; Rongey et al., 1973; Imai et al., 1994). These
investigations have led to the establishment of two feral mouse
colonies, Czech II (Gallahan and Callahan, 1987) and Jyg (Imai et al.,n, 113 Redbud Lane, Martinez,
ll rights reserved.1994). Both Czech II and Jyg mice are free of endogenous MMTV
proviruses, but they carry milk-borne MMTVs (described here as
Czech II-MMTV and Jyg-MMTV, respectively). However, the Czech II
and Jygmice differ in their incidence ofmammary tumors: the Czech II
mice develop mammary tumors at an incidence of about 20%
(Gallahan and Callahan, 1987), whereas the tumor incidence in Jyg
mice is close to 80% (Sarkar et al., 1994). This suggests that Jyg-MMTV,
like other standard laboratory MMTV strains, is highly infectious and
tumorigenic to its natural host. However, whether this virus is equally
infectious to other MMTV-free laboratory mouse strains and induces
mammary tumors has not been determined.
MMTV, like many other retroviruses, does not carry an oncogene in
its genome, and thus the mechanism by which it induces mammary
tumors in mice is presumed to be the transcriptional activation of
cellular protooncogenes as a consequence of frequent integrations of
MMTV proviral DNA near these genes. Initial studies with mammary
tumors of C3H and BR6 mice resulted in the identiﬁcation of two
protooncogenes, designated int-1 and int-2 (Nusse and Varmus, 1982;
Dickson et al., 1984), which have now been renamed asWnt-1 (Nusse
et al., 1991) and Fgf-3 (Peters et al., 1989). The majority of mammary
tumors from a variety of mouse strains appear to be induced by the
activation of Wnt-1 and/or Fgf-3 (Table 1), but other Wnt and Fgf
related genes have also been shown to be involved in a low percentage
of mammary tumors.
Another target for insertional activation by MMTV, int-3, was
identiﬁed by studying the mammary tumors of Czech II mice
(Gallahan et al., 1987). This gene is now named Notch-4 (Hook et al.,
2000). Although Notch-4 activation is rarely found to be involved in
the development of mammary tumors by standard MMTV strains, its
Table 1
MMTV-induced activation of Wnt-1, Fgf-3 and Notch-4 in mouse mammary tumors.
MMTV Host Frequency of activation (%) Reference
Wnt-1 Fgf-3 Notch-4
C3H C3H/OuJ(28) 75 22 0 A
C3H BALB/c(30) 30 30 0 A
C3H C3H(9) 100 11 ND B
C3H BALB/c(18) 39 16 ND B
RIII RIII(29) 11 59 0 A
RIII BALB/c(40) 32 25 0 A
RIII RIII(14) 57 92 0 C
RIII/Sa RIII/Sa(23) 34 20 0 D
RIII/Sa BALB/c(35) 40 17 0 D
RIII/Sa RIII/Sa(9) 33 56 11 E
BR6 BR6(10V) 80 20 10 C
BR6 BR6(30M) 70 66 7 C
BR6 BALB/c(10) 90 80 0 C
Czech II Czech II(45) 26 4 18 A
C3H Czech II(30) 30 13 3 A
Jyg Jyg(23) 26 13 43 F
Jyg BALB/c(47) 31 17 0 PS
Jyg C57BL(28) 25 11 0 PS
The number within the parentheses represents the number of tumor DNA samples
analyzed; the number followed by the letters V and M indicate that the tumors were
harvested from virgin and multiparous mice, respectively; ND indicates not done. It
should be noted that many of the tumors had concerted activation of both Wnt-1 and
Fgf-3. The letters A–F (last column) refer to the following references: Callahan and
Smith (2000); Pathak et al. (1987); Claussen et al. (1993); Sarkar (1995); Popken-
Harris et al. (2006); and Sarkar et al. (1994), respectively; PS, present study. The author
apologizes to any investigators who might feel their work should have been referred to
in this table.
Fig. 1. The pattern of mammary tumor development in BALB/c (open squares) and
C57BL/6 (black circles) female mice producing Jyg-MMTV. Initially, virus was
introduced experimentally into the female ancestors of these mice by inoculating
them with cultured cells derived from a spontaneous mammary carcinoma of a Jyg
mouse. Third parity females were forced bred andmonitored for tumor development on
a weekly basis for a period of 16 months. The survey was done with 135 BALB/c and 96
C57BL/6 mice.
Fig. 2. Evidence for the presence of newly integrated Jyg-MMTV proviral DNA in the
mammary tumors of BALB/c mice. DNA obtained from Jyg-MMTV-induced mammary
tumors (lanes 1 to 8), was digested overnight to completion with EcoRI. The DNA
digests (10–15 μg) were then size fractionated by electrophoresis through 0.8% agarose
gel, transferred to a nitrocellulose ﬁlter and hybridized to a [α-32P]-dCTP-labeled probe
representing the entire sequence of Jyg-MMTV (Xu et al., 1994). The DNA fragments
were detected by exposing the ﬁlter to X-ray ﬁlm. The sizes of the restriction fragments
shown on the right side of the panel corresponds to junction fragments containing
sequences from both the host DNA and three endogenous proviruses that BALB/c mice
carry in their genome. The bands indicated by arrowheads (lanes 1–8) represent
segments of host DNA and newly integrated Jyg-MMTV proviral fragments. Note that
the 4.3-kb band is common to all tumor DNA, and represents an internal DNA fragment
of Jyg-MMTV.
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mammary of Jyg-MMTV-infected wildmice (Sarkar et al., 1994). In the
present study we sought to 1) determine whether Jyg-MMTV is
infectious to and induces mammary tumors in exogenous MMTV-free
BALB/c and C57BL/6 mice that are commonly used in studies of the
pathogenesis of standard MMTV strains (Moore et al., 1979), and 2)
evaluate whether the mammary tumors, if induced by the virus in
these mice, resulted from the activation of Notch-4.
Results
Jyg-MMTV is infectious to both BALB/c and C57BL/6 mice and induces
mammary tumors
The pathogenecity of Jyg-MMTV was evaluated by subcutaneous
inoculation of 3 to 4-week old BALB/c and C57BL/6 female mice (5/
group) with Jyg-MMTV-producing cells derived from a mammary
tumor of a wild mouse (Sarkar et al., 1994). As expected the
transplanted cells did not produce any tumor at the site of inoculation
because of the lack of histocompatibility between the grafted cells and
the tissues of the host animals. To determine whether the cell-
inoculated mice (CIM) were, however, infected with MMTV released
from the cells, milk samples from third parity mothers were collected,
soluble antigens were prepared from semi-puriﬁed viral pellet and
tested by radial immunodiffusion (RID) using anti-MMTV antibody
(Moore et al., 1979). Although RID is neither quantitative nor sensitive,
it is very simple and provides a very good indication of the relative
levels of viral load when a large number of samples need to be tested.
Results showed that 5 of the 5 BALB/c and 3 of the 5 C57BL/6 CIM-
mice were strongly positive for virus production, indicating that Jyg-
MMTV released from the inoculated cells successfully infected the
mammary glands of most of the CIM. The third and fourth parity pups
from these MMTV-producing mice were further bred, and the animals
thus derived were kept for tumor development.
Fig. 1 shows the pattern of tumor development in Jyg-MMTV-
infected BALB/c and C57BL/6 mice. In general, both mouse strains
proved to be susceptible to virus infection, but the incidence ofmammary tumor development in BALB/c mice was higher than the
incidence of tumors that developed in C57BL/6 mice. Further, the
latency period of tumor development in the latter group of mice was
longer than what was observed in BALB/c mice. The overall tumor
incidence among the virus-infected 135 BALB/c and 96 C57BL/6 mice
reached approximately 75% and 32%, respectively, during an observa-
tion period of 16 months. The BALB/c mice thus proved to be an
excellent host for infectionwith Jyg-MMTV and subsequentmammary
tumor development.
Fig. 4. Pattern of Wnt-1 (panel A) and Fgf-3 (panel B) RNA expression in the
mammary tumors of BALB/c (lanes 1–5) and C57BL/6 mice (lanes 6 and 7). Northern
blot hybridization was done with total RNA (20 μg) prepared from freshly excised
tumors. RNA was fractionated on a 1% formaldehyde gel, transferred to nylon
membranes, and hybridized with Wnt-1 and Fgf-3-speciﬁc probes. The panels
represent the same 7 different RNA samples, but the hybridization with the two
probes were done with two different ﬁlters. The arrowheads indicate the position of
the Wnt-1 and Fgf-3 transcripts; the size of atypical Wnt-1 RNA is 2.6 kb. Fgf-3 probe
detected, as expected 3.2 kb and 3.0-kb Fgf-3 transcripts; some smaller size RNA of
unknown origin was also detected in some samples. The sizes of the RNA were
assessed relative to MMTV 35 S and 24 S mRNAs detected by hybridizing the same
blots with an MMTV probe (data not shown).
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Notch-4, in the mammary tumors of BALB/c and C57BL/6 mice
Jyg-MMTV has been shown to cause insertion mutation of three
protooncogenes,Wnt-1, Fgf-3 and Notch-4, in the mammary tumors of
Jyg mice. To address the question of whether or not these genes could
similarly be involved in the genesis of Jyg-MMTV-induced mammary
tumors in laboratory mice, we analyzed 47 and 28 mammary tumors
from BALB/c and C57BL/6 mice, respectively. Our initial approach was
to digest tumor DNA with restriction enzymes followed by the
detection of newly integrated proviruses with a viral probe (Fig. 2) to
show that the tumors were composed of clonal population of cells,
and then determine the frequency of Wnt-1, Fgf-3 and Notch-4
rearrangements (Fig. 3). The use of a DNA probe representing
sequences from the entire Jyg-MMTV genome detected newly
integrated proviral fragments in the EcoRI digests of tumor DNA
(arrowheads, Fig. 2). As expected, the number of host-viral junction
fragments (arrowheads), their sizes, and the intensity of their
hybridization varied from one tumor to the other.
Rearrangements of Wnt-1, Fgf-3 and Notch-4 caused by proviral
insertions in mammary tumor DNA were evaluated by digestion of
genomic DNA with restriction enzymes followed by Southern
hybridization with probes speciﬁc to each of the oncogenes. The
results shown in Fig. 3 clearly demonstrate that Jyg-MMTV caused
insertion mutations in Wnt-1 and Fgf-3 in some of the mammary
tumors of both BALB/c (arrowheads, Figs. 3A and B) and C57BL/6
(data not shown) mice. However, repeated tests on tumor DNA from
both mouse strains failed to detect any rearrangements of Notch-4
(Fig. 3C). Since a single 8.6-kb bandwas detected in all tumor samples,
we ruled out the possibility that there might have been some problem
with our preparation of the Notch-4-speciﬁc probe. Taken together,Fig. 3. Southern blot hybridization of the genomic DNA of Jyg-MMTV-induced
mammary tumors from BALB/c mice for the detection of host DNA rearrangements
caused by viral insertion. DNA obtained from 8 tumors (different from those shown in
Fig. 2) were digested separately with BglII (panel A), BamHI (panel B) and EcoRI (panel
C) and subjected to gel electrophoresis. DNA was transferred to ﬁlters and annealed
with [α-32P] dCTP-labeled probes speciﬁc toWnt-1, Fgf-3, and Notch-4. Note that only 2
of the 8 tumors showed insertional mutation in Wnt-1 (panel A) and Fgf-3 (panel B),
but none in Notch-4 (panel C).we concluded that Jyg-MMTV is able to induce mammary tumors in
other laboratory mouse strains, but the virus did not cause insertion
mutation to Notch-4, in contrast to Wnt-1 and Fgf-3.
Notch-4 is not activated in Jyg-MMTV-induced mammary tumors of
BALB/c and C57BL/6 mice
Our inability to detecting Notch-4 rearrangements in tumors by
Southern hybridizations could probably be attributed to viral integra-
tions occurring at considerable distances from the gene so that the
particular probe and the restriction enzyme used for the analyses
were not effective. Since one of the primary objectives of this study
was to answer the question of whether or not Jyg-MMTV targets
Notch-4 in the mammary tumors of both BALB/c and C57BL/6 mice,
we resorted to the detection of the expression of Notch-4-speciﬁc 2.4-
to 3.6-kb transcripts (Gallahan et al., 1987; Sarkar et al., 1994) in 47
BALB/c- and 28 C57BL/6-mammary tumors. The expression patterns
of Wnt-1 and Fgf-3 were also examined by Northern blotting as
controls. The Wnt-1-speciﬁc DNA probe identiﬁed in the mammary
tumors only one type of RNA molecule, the size of which ranged from
2.6 kb to 3.8 kb (Fig. 4A). As expected, an Fgf-3-speciﬁc probe detected
two species of RNA molecules, 3.0 kb and 3.2 kb in size (Fig. 4B). It
should be that noted that similar variations in the sizes of bothWnt-1
and Fgf-3 transcripts have been observed in the mammary tumors of
C3H (Nusse et al., 1984) and BR6 (Peters et al., 1986, 1989) mice.
Overall, 12 of the 47 mammary tumors from BALB/c mice were found
to be positive for Wnt-1 rearrangement by Southern hybridization.
Four additional tumors scored positive for Wnt-1 expression, indicat-
ing that nearly 34% of the mammary tumors of BALB/c mice had
MMTV integrations at the Wnt-1 loci (Table 1). Similar analyses
revealed the frequency of Fgf-3 activation to be only 17% (see Table 1).
The frequency at which Jyg-MMTV caused insertion mutation toWnt-
1 and Fgf-3 in the mammary tumors of C57BL/6 mice were 25% and
11%, respectively.
Fig. 5. Lack of Notch-4 expression in Jyg-MMTV-induced mammary tumors of BALB/c
(lanes 1–7; panel A) and C57BL/6 (lanes 8 and 9; panel A) mice. Lane 10 represents an
RNA sample prepared from a mammary tumor developed in a Jyg mouse infected with
Jyg-MMTV. The same RNA ﬁlter was sequentially hybridized with MMTV (panel B)- and
actin (panel C)-speciﬁc probes as controls.
Fig. 6. The virions produced by Jyg-MMTV-infected C57BL/6 (lanes 3 and 4) and BALB/c
(lanes 5 and 6) mice contain C-terminal sag sequences identical to the wild type virus.
(A) RT-PCR products were synthesized from RNA prepared from the mammary glands,
(MG, lanes 3 and 5) of high parity mothers and mammary tumors (T, lanes 4 and 6).
Lanes 1 and 2 represent marker DNA (M), and RT-PCR of MG-RNA (C) from an MMTV-
uninfected mouse. Note that RNA from virus-infected mice produced similar sized
(486 bp) RT-PCR products. (B) Alignment of the highly variable last 23 C-terminal
amino acid sequences of C3H-MMTV and Mtv-17 with the terminal sequences of Jyg-
MMTV produced by Jyg, C57BL/6, and BALB/c mice. The letters L and W in column one
indicates laboratory and wild mouse, respectively.
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Notch-4-speciﬁc transcript, total cellular RNA extracted from the
tumors were analyzed by Northern hybridizations. The same ﬁlters
were also hybridized with MMTV- and actin-speciﬁc probes as
positive controls to asses the quality of RNA. Some examples of the
results that we observed consistently are shown in Fig. 5: Notch-4
speciﬁc probe (panel A) failed to detect the presence of Notch-4
transcripts in all 7 RNA samples (lanes 1–7) obtained from 7
individual tumors of BALB/c mice as well as in 2 RNA samples
prepared from two different tumors of C57BL/6 mice (lanes 8 and 9).
However, the probe produced a strong hybridization signal (lane 10)
with an RNA prepared from one spontaneous mammary tumor of a
Jyg mouse (Sarkar et al., 1994). Subsequent hybridizations with the
same ﬁlter with MMTV (panel B) and actin (panel C) probes detected,
as expected, the two major MMTV transcripts, 70 s and 35 s, and the
2.4-kb actin RNA. These observations clearly indicate that Notch-4
activation do not occur in Jyg-MMTV-induced mammary tumors of
heterologous hosts, such as BALB/c and C57BL/6 mice. This is
surprising since in a previous study we demonstrated Jyg-MMTV to
cause rearrangements of Notch-4 in the mammary tumors of Jyg mice
at an incidence of 43% (Sarkar et al., 1994).
Discussion
The present study shows that Jyg-MMTV infection results in the
development mammary tumors in BALB/c mice with an incidence
higher than that in C57BL/6 mice. Although the reason why nearly
70% of the virus-infected C57BL/6 mice failed to develop mammary
tumors is not known, it is possible that host-viral interactions, and/or
some structural changes in the viral genome during its replicative
cycles may have contributed to this problem. One study has suggested
an immunological basis in a C3H-MMTV model, for the lower
incidence of tumors seen in C57BL/6 mice compared to BALB/c
mice (Wrona and Dudley, 1996). Virus-infected C57BL/6 mice were
found to produce MMTV during their ﬁrst lactation at levels lower
than the amounts of virions produced by BALB/c mice because, unlike
BALB/c mice, C57BL/6 mice lack major histocompatibility complex
class II I-E molecules which are needed for efﬁcient MMTV transmis-
sion (Held et al., 1994). Interestingly, this study also showed that the
levels of MMTV production in both mouse strains become comparable
during subsequent lactations. Thus onewould expect C57BL/6 mice to
have delayed tumor appearance, but if these mice are observed for
more than 12 months, their cumulative tumor incidence should be
comparable to those of BALB/cmice. This expectationwas not realized
in our experiment despite the fact that we infected both C57BL/6 andBALB/c mice with Jyg-MMTV from the milk of third parity mothers,
and theyweremonitored for 16months for tumordevelopment (Fig.1).
Further, some earlier studies have shown C57BL/6 mice to be more
susceptible to RIII-MMTV than BALB/cmice (Moore et al.,1979). Taken
together, it appears therefore that the absence of class II I-E molecules
in C57BL/6 mice may not be the reason for their low tumor incidence.
In a C3H-MMTV infected C3H/HeJ mouse model, it had been
observed that the later generations of these mice, although continued
to express MMTV, exhibited a decline in tumor incidence and
increase in tumor latency (Outzen et al., 1985). The basis for this
change in tumor incidence has been attributed to structural changes
in the original viral genome: the virus presently expressed by C3H/
HeJ mice is a genetic recombinant between a high tumor-inducing
exogenous C3H-MMTV and a low tumor-inducing endogenous
provirus, Mtv-1 (Hook et al., 2000). A similar type of recombination
between JYG-MMTV and Mtv-1 cannot occur in Jyg-MMTV-infected
C57BL/6 mice simply because the genome of this mouse strain does
not carry Mtv-1 (Kozak et al., 1987). However, other endogenous
MMTV(s), such as Mtv-17 that is present in the genome of C57BL/6
mice, may recombine with Jyg-MMTV in our virus-infected animals
and negatively regulate tumor development. There is a precedent
that recombinant virus containing the 3′-half of the genome of Mtv-
17 and the 5′-half of the genome of milk-borne GR-MMTV play a role
in mammary tumor development in GR mice (Golovkina et al., 1996).
Therefore, RNA isolated from tumors and tumor free-lactating
mammary glands of Jyg-MMTV-infected C57BL/6 and BALB/c mice
were analyzed by RT-PCR ampliﬁcation of a segment of the orf gene
and sequencing by following the procedure that we used earlier
(Sarkar et al., 2004). Our preliminary study produced no evidence for
the incorporation of neither Mtv-17 orf nor the orf of other
endogenous Mtvs in the genome of parental Jyg-MMTV with which
both C57BL/6 and BALB/c mice were infected (Fig. 6). Recent studies
have shown the roles of viral gag and env genes as well as a cellular
factor in mammary tumor development (Hook et al., 2000; Ross et
al., 2006; Swanson et al., 2006). It is possible that the inability of
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to a cellular factor(s) that confers tumor resistance unlike the mts-
associated tumor susceptibility gene that has recently been char-
acterized (Swanson et al., 2006).
The present study clearly shows that Jyg-MMTV-induced mam-
mary tumors of BALB/c and C57BL/6 mice do contain activatedWnt-1
and Fgf-3, but not Notch-4. One previous study that compared the
patterns of Wnt-1 and Fgf-3 activations by C3H- and RIII-MMTV-
induced mammary tumors from native and experimental animals
indicated that the genetic background of the host inﬂuenced the
frequency of their activities in the tumors (Marchetti et al., 1991).
Interestingly, the involvement of Fgf-3 in mammary tumors from
multiparous GR mice has been found to be signiﬁcantly higher (70–
90%) than in those tumors (20%) derived from virgin mice (Claussen
et al., 1993). These authors suggested that the frequency of oncogene
activation by MMTV is probably inﬂuenced more by the hormonal
status of the mice than by their genetic background. An overview of
the available results on the frequencies of proviral disruption inWnt-1
and Fgf-3 (Table 1) reveals no consistent pattern in favor of any of
these two opposing hypotheses. The contributory factors to this
problem may include differences in sample size analyzed by different
groups of investigators, the choice of their host-viral systems, and the
diligence with which these loci were perused.
The situation with Jyg-MMTV-induced tumors of both BALB/c and
C57BL/6 mice seems to be special: the virus activates Notch-4 in Jyg
mice, but the virus most likely fails to incorporate into sequences
neighboring the transcriptional unit of this protooncogene in both
BALB/c and C57BL/6 mice. It is a prevailing idea that the presence of
common retroviral integrations observed in tumors is due to the
selection of cells containing mutations in speciﬁc genes during tumor
progression rather than the virus targeting speciﬁc oncogenic locus. In
this context, Notch-4 may be weakly oncogenic in our host-viral
system and thus Wnt-1 and Fgf-3 activated tumor cells outgrew the
Notch-4 activated cells. Alternatively, site-speciﬁcity of viral integra-
tion may explain our observations since several studies have shown
the existence of highly preferred targets for retroviral integrations
(Shih et al., 1988; Mnller and Varmus, 1994; Maxﬁeld et al., 2005;
Kumar et al., 2007).
Materials and methods
Mice and cells
Two strains of exogenous MMTV-free BALB/c and C57BL/6 mice
raised in our own colony were housed in sterilized cages (4–5 mice/
cage). They were kept on a 12-h light–dark cycle and allowed to
receive laboratory chow food and water ad libitum. Viral infection in
these mice was initiated by inoculation of a Jyg-MMTV-producing cell
line (Jyg-MT) following a previously published procedure (Shackle-
ford and Varmus, 1988). It should be mentioned that this cell line was
established from a mammary carcinoma of a wild Jyg mouse (Imai et
al., 1994), and has been shown to produce large amount of MMTV and
to contain activated Notch-4 (Sarkar et al., 1994). The Jyg-MT cells
were grown in monolayers at 37 °C in Dulbecco's Modiﬁed Eagle's
media (DMEM) (Gibco, BRL, NY), and prior to harvest the cells were
treated with dexamethasone (2 μg/ml) for 48 h in order to boost virus
production (Sarkar et al., 1977).
Viral infection and tumor development
To derive Jyg-MMTV-producing mouse lines, 3 to 4-week old
BALB/c and C57BL/6 female mice (5/group) were inoculated
subcutaneously with 2×106 Jyg-MMTV-producing cultured cells at
four sites near the second and fourth pairs of mammary glands. Cell-
inoculated mice (CIM) were force-bred, and milk samples obtained
from the third parity mothers were tested by a simple immunodiffu-sion (ID) procedure for the presence of MMTV (Moore et al., 1979). To
conduct this test lactating mice, 8 to 12 days post-partum, were
separated from their pups for 12 to 18 h and were injected
intraperitoneally with 0.2I U of oxytocin (Sandoz, Basel, Switzerland)
30 min prior to milking. Milk was then aspirated with a manual
peristaltic suction pump, diluted 1:20 with a solution containing
0.02 M phosphate buffered saline (PBS), pH 7.4, and 0.15 M EDTA, and
centrifuged at 1000 ×g for 10 min. The fat layer and cell pellet were
removed, themilk serumwas centrifuged at 20,000 ×g for 1 h, and the
partially puriﬁed viral pellet was re-suspended in 50 μl of PBS and
extracted with ether to generate soluble MMTV antigens. Virus
producing mice were used for further breeding, and the animals thus
derived were kept for tumor development. Time of tumor appearance
was noted by palpating their mammary glands on a weekly basis.
Southern blot hybridization
Mammary tumors of varying sizes were collected from 47 BALB/c
and 28 C57BL/6 mice, and analyzed both by Southern and Northern
hybridizations with probes speciﬁc to Wnt-1, Fgf-3, and Notch-4
genes. Each tumor was divided into a minimum of 3 segments, two of
which were processed as soon as possible for DNA and RNA
extractions while the other fragment(s) was snap frozen in liquid
nitrogen for further use. Some DNA/RNA samples were also prepared
from frozen tumors. DNA extraction was done with phenol/chloro-
form treatment of homogenized tissues following the procedure that
we used previously (Imai et al., 1994).
Ten to 15 μg of DNA was digested overnight with restriction
enzymes EcoRI, BglII and/or BamHI under conditions recommended
by the supplier (Promega), size fractionated by electrophoresis
through 0.8% agarose, and transferred to nitrocellulose ﬁlters follow-
ing a standard procedure (Sambrook et al., 1989). The ﬁlters were
prehybridized and then DNA was annealed with probes speciﬁc to
Wnt-1, Fgf-3, and Notch-4. The composition of the probes were as
follows (Sarkar, 1995): Wnt-1, a 2.5-kb EcoRI–BamHI fragment of the
Wnt-1 locus; Fgf-3, 1.8-kb EcoRI–SacI and 1.7-kb EcoRI–EcoRI
fragments of the Fgf-3 locus; and Notch-4, a 2.4-kb XbaI–KpnI
fragment of the Notch-4 locus. All probe-speciﬁc DNA fragments
were isolated from plasmid vectors and labeled with α-32P-dCTP by
using an Oligolabeling kit (Pharmacia). Unincorporated radioactivity
was removed with Nu-trap push columns (Stratagene); speciﬁc
activity of the labeled DNA ranged from 7×107 to 1.2×108 cpm/μg.
Hybridization of DNA ﬁlters with appropriate probes and the
detection of radioactive signals were done according to the procedure
that we used earlier (Sarkar, 1995).
Northern blot hybridization
Freshly excised mammary tumors or frozen tissues were homo-
genized with a polytron homogenizer in the presence of 6 M urea and
3 M LiCl followed by phenol/chloroform/isoamyl alcohol (25:24:1)
extractions (Roelink et al., 1992). The RNAwas kept in 50% isopropanol
and stored at−20 °C. For Northern hybridizations, 15–20 μg RNAwas
denatured at 60 °C for 10 min in a solution containing 50% formamide,
2.2 M formaldehyde, and an RNA electrophoresis buffer (20 mM
MOPS, 5mM sodium acetate, and 1mMEDTA). The RNA samples were
then electrophoresed in 1% agarose gels using the same buffer system
with an addition of 4% formaldehyde, transferred to Zeta Probe ﬁlters
in the presence of 20 × SSC, and cross-linked by a Stratagene UV
Stratalinker.
The ﬁlters were hybridized with approximately 5×107 cpm
radioactive probes, speciﬁc to Wnt-1, Fgf-3, and Notch-4, in a mixture
of 0.2 M Na2HPO4, 1 mM EDTA, 1% BSA, 7% SDS and 16% formamide
for 20 to 24 h at 65 °C. Following hybridization, the ﬁlters were
washed three times in a solution of 0.04 M Na2HPO4, 5% SDS, and
0.001 mM EDTA at 65 °C and exposed to Kodak X-ray ﬁlm for
126 N.H. Sarkar / Virology 388 (2009) 121–127autoradiography. All ﬁlters were re-hybridized twice with two
different probes after removal of the previous probes by washing in
1% glycerol for 4 h at 80 °C. The additional probes used were: cloned
Jyg-MMTVrep representing the entire sequences of Jyg viral DNA (Xu
et al., 2000) and actin, a 0.3-kb PstI–PstI fragment of chicken γ-actin
(Cleveland et al., 1980).
PCR
The virions produced by Jyg-MMTV-infected BALB/c and C57BL/6
mice were tested for possible genomic alterations due to recombina-
tion with endogenous MMTVs. Total RNA was isolated from tumor
cells and partially puriﬁed milk-borne virions by using a TRIzol kit
(GIBCO-BRL), polyA selected, and were subjected to RT-PCR ampliﬁ-
cation of a segment of the viral LTR. The following two primers were
used: forward primer (FP), 5′ (751)- TTT CGT GAA AGA CTC GCC A-
(769)-3′; reverse primer (RP) 5′ (1237)- GGA CTG TTG CAA GTT TAC
TC- (1218)-3′. The FP represented a region of Jyg-MMTV LTR about
475 bp upstream to the R domain while the RP contained sequences
from the 3′ end of the U3 and R regions. It should be noted that both FP
and RP sequences share homology to otherMMTVs, and the size of the
PCR product was expected to be 486 bp for Jyg-MMTV compared to a
value of 448 bp for C3H-MMTV (Xu et al., 1994; Wrona et al., 1998).
To prepare viral cDNA, RNAwas incubatedwith RP (20 pM) at 70 °C
for 10 min., chilled on ice for 2 min., and then mixed with 5 units of
AMV-RT in a RT reaction buffer (Promega), and incubated at 37 °C for
1 h. PCR ampliﬁcation was done by mixing 3–5 μl of cDNAwith dNTPs
(5 mM), FP and RP primers (20 pM), and Taq polymerase (1 unit,
Fisher). The reaction conditions were: 95 °C, 1 min; 60 °C, 30 s; 72 °C,
1 min (1 cycle); 94 °C, 30 s; 58 °C,1 min; 72 °C,1.5 min (1 cycle); 94 °C,
23 s; 58.5 °C, 30 s; 72 °C, 1.5 min (30 cycles); 94 °C, 45 s; 58 °C, 45 s;
72 °C, 5 min (1 cycle).
The PCR productswere analyzed byelectrophoresis on 1.5% agarose
gels, the bands of interest were puriﬁed using GenElute™Minus EtBr
Spin columns (Supelco, Bellefonte, PA) followed by precipitation with
glycogen (Sarkar et al., 2004). DNA was cloned into pGEM-T® Easy
Vector Systems II (Promega) and positive clones expanded. Plasmid
DNA was isolated using Wizard® plus DNA Puriﬁcation System
(Promega) and sequenced using SP6 and T7 promoters.
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